(NYSE:DBRG),(NYSE:DBRG.PRH),(NYSE:DBRG.PRI),(NYSE:DBRG.PRJ), MONSEY, New York, Jan. 13, 2026 (GLOBE NEWSWIRE) — The law firm of Wohl & Fruchter LLP is investigating the proposed sale of DigitalBridge Group, Inc. (NYSE: DBRG) (“DigitalBridge”) to SoftBank for $16.00 per share in cash on behalf of holders of DigitalBridge Preferred Stock Series H (NYSE: DBRG.PRH), Series I (NYSE: DBRG.PRI) and […]

(NASDAQ:IPW), RANCHO CUCAMONGA, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”) today announced its recent participation at a Event hosted by Zyla by Ant International (“Zyla”). The Company was introduced as a U.S. retail channel partner supporting Zyla's clients, highlighting iPower's expertise in expanding their online sales presence

(NASDAQ:CELZ), PHOENIX, Jan. 13, 2026 (GLOBE NEWSWIRE) — Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced positive interim 180-day follow-up data from its FDA-cleared ADAPT clinical trial evaluating CELZ-201 (Olastrocel), the Company's proprietary perinatal tissue-derived cell therapy for chronic lower back

Bristow Group Inc. (NYSE: VTOL) (the “Company” or “Bristow”) announced today that it has commenced, subject to market conditions and other factors, a private offering of $400 million aggregate principal amount of senior secured notes due 2033 (the “notes”) to eligible purchasers pursuant to Rule 144A and Regulation S under the Securities Act of 1933,

(NASDAQ:NOTV), WEST LAFAYETTE, Ind., Jan. 13, 2026 (GLOBE NEWSWIRE) — Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced a strategic initiative to leverage LifeNet Health's proprietary TruVivo(R) within its Discovery

(NASDAQ:NXXT), MIAMI, FL, Jan. 13, 2026 (GLOBE NEWSWIRE) — NextNRG, Inc. (NASDAQ: NXXT), a pioneer in AI-driven energy innovation transforming how energy is produced, managed, and delivered, today highlighted that its previously announced healthcare microgrid power purchase agreements (PPAs) validate a scalable, vertical-focused infrastructure approach for long-term deployment in mission-critical energy markets. Executed agreements across

Signing Day Sports Announces Pricing of $5.6 Million Public Offering GlobeNewswire January 13, 2026 SCOTTSDALE, Arizona, Jan. 13, 2026 (GLOBE NEWSWIRE) — Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American: SGN), the developer of the Signing Day Sports app and platform to aid high school athletes in the recruitment process, today

DBRG Alert: Monsey Firm of Wohl & Fruchter Investigating the Sale of DigitalBridge on Behalf of Preferred Stockholders GlobeNewswire January 13, 2026 MONSEY, New York, Jan. 13, 2026 (GLOBE NEWSWIRE) — The law firm of Wohl & Fruchter LLP is investigating the proposed sale of DigitalBridge Group, Inc. (NYSE: DBRG) (“DigitalBridge”) to SoftBank for $16.00

iPower Highlights Channel Partner Role at Zyla by Ant International Event During Consumer Electronics Show GlobeNewswire January 13, 2026 RANCHO CUCAMONGA, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”) today announced its recent participation at a Event hosted by Zyla by Ant International (“Zyla”). The Company was introduced

Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain Data Show Strong Functional and Pain Improvements Supported by Excellent Safety Profile GlobeNewswire January 13, 2026 PHOENIX, Jan. 13, 2026 (GLOBE NEWSWIRE) — Creative Medical Technology Holdings, Inc.